Publications in Statistical Modeling of Health Services Utilization and Outcomes

The number of cancer survivors in the United States is increasing due to more effective diagnosis and treatment. While cost-effectiveness analysis offers decision-makers a rational way to improve the return on resources expended, estimates of the costs of medical care vary across patient populations, data sources, and methods. The following studies explore approaches for estimating the burden of illness for cancer survivors and costs of cancer care.

Mariotto AB, Yabroff KR, Shao Y, Feuer EJ, Brown ML. Projections of the Cost of Cancer Care in the United States: 2010-2020. JNCI 2011 Jan 19; Vol. 103, No. 2. [Abstract]

Dowling E, Yabroff KR, Mariotto A, McNeel T, Zeruto C, Buckman D. Burden of illness in adult survivors of childhood cancers: findings from a population-based national sample. Cancer 2010 Aug 1;116(15):3712-21. [Abstract]

Yabroff KR, Warren JL, Banthin J, Schrag D, Mariotto A, Lawrence W, Meekins A, Topor M, Brown ML. Comparison of approaches for estimating prevalence costs of care for cancer patients: what is the impact of data source? Med Care 2009 Jul;47(7 Suppl 1):S64-9. [Abstract]

Yabroff KR, Warren JL, Schrag D, Mariotto A, Meekins A, Topor M, Brown ML. Comparison of approaches for estimating incidence costs of care for colorectal cancer patients. Med Care 2009 Jul;47(7 Suppl 1):S56-63. [Abstract]

For use of cancer prevalence in cost projections, please visit the Cancer Prevalence and Cost of Care Projections web site.